ArticleOncoTargets and therapy2020

Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells for a Pediatric Ph-Like B-ALL Patient That Relapsed After CART-Cell and Haplo-HSCT Therapy: A Case Report and Review of Literature.

Jingsheng Hua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.